A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
Trials
; 22(1): 288, 2021 Apr 19.
Article
in En
| MEDLINE
| ID: mdl-33874981
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Respiratory Distress Syndrome
/
Alpha 1-Antitrypsin
/
COVID-19 Drug Treatment
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Guideline
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Trials
Journal subject:
MEDICINA
/
TERAPEUTICA
Year:
2021
Type:
Article
Affiliation country:
Ireland